Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 60.81 -1.30%   SPY: 129.74 -0.86%
Quote Spy AKRX NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Akorn (AKRX)

@ May-18
Click the portfolio to add AKRX:
Close [X]
+ Add AKRX to Portfolio
  
  Last Trade: $12.95 +0.07 (0.54%)
  Volume: 1,136,674 103% of avg daily volume
       
  Avg Volume: 1,105,904
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 12.79 - 13.09
  Open: 12.87
  Previous Close: 12.88
  52-wk Range: 6.18 - 13.25
  Market Cap: 1.2B
  P/E: 30.0
  Div Yield: $0.00 (0.00%)
Indexes
Ophthalmology and Ey... (-2.2%)
Spy AKRX

? Pro holders
? Member holders
? Items submitted
Additional AKRX resources



Customize Links
To see which Pros and tickerspy members own AKRX Sign up now
Latest AKRX Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

ViroPharma Loses Bid for Order Blocking Generic Vancocin
AKRX  WPI  VPHM  
Linked by Bloomberg - April 24, 01:07PM from (www.bloomberg.com)
ViroPharma Inc. (VPHM) lost a bid for a court order temporarily blocking U.S. Food and Drug Administration marketing approval  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
ViroPharma Seeks Temporary FDA Block for Generic Vancocin
AKRX  WPI  VPHM  
Linked by Bloomberg - April 13, 06:52PM from (www.bloomberg.com)
ViroPharma Inc. (VPHM) sued two federal agencies seeking a court order temporarily blocking approval of generic forms of its biggest product, the antibiotic Vancocin.
 more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
End-of-Day Market Summary for December 23, 2011
AKRX  TLM  CHCO  [PARL]  PERF  LAVA  ONNN  VOLC  
Linked by Benzinga.com - December 23, 04:18PM from (www.benzinga.com)
This is your Benzinga news summary for Friday, December 23, 2011, covering headlines from Friday's daytime trading session.
 more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Big Values In Big Pharma
AKRX  FRX  LLY  PFE  AZN  ONXX  XPH  IHE  IHI  
Linked by Investopedia Stock Analysis - November 01, 01:00PM from (stocks.investopedia.com)
The major pharmaceutical firms now represent value. These companies could represent a great income play.  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Akorn Reports Third Quarter 2010 Results
AKRX  
Linked by BusinessWire - November 01, 05:39PM from (www.businesswire.com)
Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today reported financial results for the third quarter  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Akorn Reports Second Quarter 2010 Results
AKRX  
Linked by BusinessWire - August 03, 08:00AM from (www.businesswire.com)
Akorn, Inc. (NASDAQ:AKRX), a niche generic pharmaceutical company, today reported financial results for the second quarter  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Akorn Reports First Quarter 2010 Financial Results
AKRX  
Linked by BusinessWire - May 03, 05:25PM from (www.businesswire.com)
Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today reported financial results for the first quarter  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource